D. Boral Capital is acting as the Sole Placement Agent for the offering. Mobix Labs, Inc intends to use the net proceeds from the offering for working capital and general corporate purposes.

Mobix Labs, Inc. intends to use the net proceeds from the offering for working capital and general corporate purposes, including to accelerate the Company's growth initiatives and advance its M&A ...

Cadence today announced a Chiplet Spec-to-Packaged Parts ecosystem to reduce engineering complexity and accelerate time to market for customers developing chiplets targeting physical AI, data center, ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Discover key differences between trade names and trademarks, their legal roles, and why registration matters for business ...

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...

Elo ? now part of Zebra Technologies ? today announced it will introduce three new products at NRF 2026, Jan. 11?13, in booth #5803 at the Jacob K. Javits Convention Center in New York City. The new ...

Macworld 2026 could be one of the most memorable years in Apple’s history. Here’s what to expect from Apple in the first half ...

Robot’s bankruptcy has turned a familiar household helper into a source of anxiety, as Roomba owners suddenly have to think ...

Detailed price information for Werewolf Therapeutics Inc (HOWL-Q) from The Globe and Mail including charting and trades.

It’s at least the third ruling against the president’s March executive order targeting state election processes.